IRCT20190618043934N7 IRCT 2020-08-04 Birjand University of Medical Sciences The effect of fluticasone, budesonide and mometasone on nasal polyposis Comparison of the effect Sprays of fluocycan, boutsonide and mometazone in patients with nasal-sinus polyposis after sinus endoscopic surgery 2020-06-30 anticipated 32 Complete https://irct.ir/trial/49711 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The placement of individuals in each group will be randomly simple and blocked, which will be in one of three groups A (fluticasone spray), intervention B (budsonide spray) or group C (mometasone spray). First, various triple blocks are created on different cards (ABC, CAB, CBA, BCA, BAC and ACB). One of these blocks is randomly selected and patients will be divided into one of three groups A, B or C. Then randomization is performed for other patients, Blinding description: Outcome Assessor: The ward nurse, without knowing the type of medication received, questions the patients and records them in the relevant checklist. 3 Nasal polyps. Intervention 1: Intervention group 1: Group A receiving fluticasone nasal spray twice a day, 0.1 mg (manufactured by Jaber Bin Hayan Pharmaceutical Company) for 4 weeks. Intervention 2: Intervention group 2: Group B receiving Budesonide nasal spray twice a day, 0.1 mg (manufactured by Jaber Bin Hayan Pharmaceutical Company) for 4 weeks. Intervention 3: Intervention group 3: Group C receiving Mometasone nasal spray twice a day, 0.1 mg (manufactured by Jaber Bin Hayan Pharmaceutical Company) for 4 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no need to publish individual patient information